Proteomic approach for characterization of immunodominant membrane-associated 30- to 36-kilodalton fraction antigens of Leishmania infantum promastigotes, reacting with sera from Mediterranean visceral leishmaniasis patients

Clinical and Diagnostic Laboratory Immunology

Volumn 12, Issue 2, 2005, Pages 310-320

  Kamoun Essghaier, Sayda ^a   Guizani, Ikram ^a   Strub, Jean Marc ^c   Van Dorsselaer, Alain ^c   Mabrouk, Kamel ^c   Ouelhazi, Lazhar ^b   Dellagi, Koussay ^a  

^a PASTEUR INSTITUTE OF TUNIS   (Tunisia)

^b Institut National de Recherche Scientifique et Technique Tunis   (Tunisia)

^c CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; ADENINE NUCLEOTIDE TRANSLOCASE; ALDEHYDE REDUCTASE; CYTOCHROME B5 REDUCTASE; ELONGATION FACTOR 1ALPHA; GUANINE NUCLEOTIDE BINDING PROTEIN; IRON SULFUR PROTEIN; LACK ANTIGEN; LEISHMANIA INFANTUM ANTIGEN; PARASITE ANTIGEN; UBIQUINOL CYTOCHROME C REDUCTASE; UNCLASSIFIED DRUG; ANTISERUM; EPITOPE; MEMBRANE ANTIGEN; MEMBRANE PROTEIN; PROTOZOON ANTIBODY;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EUKARYOTIC CELL; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; LEISHMANIA INFANTUM; LEISHMANIA MAJOR; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROMASTIGOTE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; TIME OF FLIGHT MASS SPECTROMETRY; TWO DIMENSIONAL GEL ELECTROPHORESIS; VISCERAL LEISHMANIASIS; ANIMAL; ASIA; BLOOD; CHEMISTRY; IMMUNOLOGY; METHODOLOGY; MOLECULAR GENETICS; POLYACRYLAMIDE GEL ELECTROPHORESIS; SOUTHERN EUROPE;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; ANTIGENS, SURFACE; ASIA; CHROMATOGRAPHY, LIQUID; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; IMMUNE SERA; IMMUNODOMINANT EPITOPES; LEISHMANIA INFANTUM; LEISHMANIASIS, VISCERAL; MASS SPECTROMETRY; MEDITERRANEAN REGION; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; PROTEOMICS;

EID: 22044436634     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.12.2.310-320.2005     Document Type: Article

References (63)

1. Anonymous. 1990. Control of leishmaniases. Report of a WHO expert committee. WHO Tech. Rep. Ser. 793:1-158.
2. Badaro, R., D. Benson, M. C. Eulalio, M. Freire, S. Cunha, E. M. Netto, D. Pedral-Sampaio, C. Madureira, J. M. Burns, R. L. Houghton, J. R. David, and S. G. Reed. 1996. rK39: a cloned antigen of Leishmania chagasi that predicts active visceral leishmaniasis. J. Infect. Dis. 173:758-761.
3. Badaro, R., S. G. Reed, A. Barral, G. Orge, and T. C. Jones. 1986. Evaluation of the micro enzyme-linked immunosorbent assay (ELISA) for antibodies in American visceral leishmaniasis; antigen selection for detection of infection-specific responses. Am. J. Trop. Med. Hyg. 35:72-78.
4. Badaro, R., S. G. Reed, and E. M. Carvalho. 1983. Immunofluorescent antibody test in American visceral leishmaniasis: sensitivity and specificity of different morphological forms of two Leishmania species. Am. J. Trop. Med. Hyg. 32:480-484.
5. Ben Salah, A., R. Ben-Ismaïl, F. Amri, S. Chlif, F. Ben Rzig, H. Kharrat, H. Hadhri, M. Hassouna, and K. Dellagi. 2000. Investigation of the spread of human visceral leishmaniasis in central Tunisia. Trans. R. Soc. Trop. Med. Hyg. 94:382-386.
6. Bente, M., S. Harder, M. Wiesgigl, J. Heukeshoven, C. Gelhaus, E. Krause, J. Clos, and I. Bruchhaus. 2003. Developmentally induced changes of the proteome in the protozoan parasite Leishmania donovani. Proteomics 3:1811-1829.
7. Berneman, A., X. Rolland, and G. Broun. 1988. Humoral response in Leishmania infantum clinical infections. Ann. Inst. Pasteur Immunol. 139:267-278.
8. + T cells that induce gamma Interferon production in patients with localized cutaneous leishmaniasis during an early stage of infection. Infect. Immun. 70:3122-3129.
9. Bradford, M. 1976. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
10. Bray, R. S. 1976. Immunodiagnosis of leishmaniasis, p. 66-76. In S. Cohen and E. H Sadun (ed.), Manual of immunology of parasitic infections. Blackwell Scientific Publications, London, United Kingdom.
11. Burns, J. M., Jr., W. G. Shreffler, D. R. Benson, H. W. Ghalib, R. Badaro, and S. G. Reed. 1993. Molecular characterization of a kinesin-related antigen of Leishmania chagasi that detects specific antibody in African and American visceral leishmaniasis. Proc. Natl. Acad. Sci. USA 90:775-779.
12. Chulay, J. D., and A. D. M. Bryceson. 1983. Quantification of amastigotes of Leishmania donovani in smears of splenic aspirates from patients with visceral leishmaniasis. Am. J. Trop. Med. Hyg. 32:475-479.
13. Evans, T. G., E. C. Krug, M. E. Wilson, A. W. Vasconcelos, J. E. De Alencar, and R. D. Pearson. 1989. Evaluation of antibody responses in American visceral leishmaniasis by ELISA and immunoblot. Mem. Inst. Oswaldo Cruz 84:157-166.
14. Fargeas, C., M. Hommel, R. Maignon, C. Dourado, M. Monsigny, and R. Mayer. 1996. Synthetic peptide-based enzyme-linked immunosorbent assay for serodiagnosis of visceral leishmaniasis. J. Clin. Microbiol. 34:241-248.
15. Flinn, H. M., D. Rangarajan, and D. F. Smith. 1994. Expression of hydrophilic surface protein in infective stages of Leishmania major. Mol. Biochem. Parasitol. 65:259-270.
16. Ghedin, E., W. W. Zhan, H. Charest, S. Sundar, R. T. Kenney, and G. Matlashewski. 1997. Antibody response against a Leishmania donovani amastigote-stage-specific protein in patients with visceral leishmaniasis. Clin. Diagn. Lab. Immunol. 4:530-535.
17. Gonzalez-Aseguinolaza, G., S. Taladriz, A. Marquet, and V. Larraga. 1999. Molecular cloning, cell localization and binding affinity to DNA replication proteins of the p36/LACK protective antigen from Leishmania infantum. Eur. J. Biochem. 259:909-916.
18. Handman, E., A. H. Osborn, F. Symons, R. van Driel, and R. Cappai. 1995. The Leishmania promastigote surface antigen 2 complex is differentially expressed during the parasite life cycle. Mol. Biochem. Parasitol. 74:189-200.
19. Harith, A. E., A. H. J. Kolk, P. A. Kager, J. Leeuwenburg, R. Muigai, S. Kiugu, S. Kiugu, and J. J. Laarman. 1986. A simple and economical direct agglutination test for serodiagnosis and seroepidemiological studies of visceral leishmaniasis. Trans. R. Soc. Trop. Med. Hyg. 80:583-587.
20. Hayshi, Y., R. Urade, S. Utsumi, and M. Kilo. 1989. Anchoring of a peptide elongation factor EF-1α by phosphatidylinositol at the endoplasmic reticulum membrane. J. Biochem. 106:560-563.
21. Ho, L. C., A. Armiugam, K. Jeyaseelan, E. H. Yap, and M. Singh. 2000 Blastocystis elongation factor-lalpha: genomic organization, taxonomy and phylogenetic relationships. Parasitology 121:135-144.
22. Hoerauf, A., P. Andrade, C. R. Andrade, W. Solbach, and M. Rollinghoff. 1992. Immunoblotting as a valuable tool to differentiate human visceral leishmaniasis from lymphoproliferative disorders and other clinically similar diseases. Res. Immunol. 143:375-383.
23. Hommel, M., W. Peters, J. Ranque, M. Quilici, and G. Lanotte. 1978. The micro-ELISA technique in the serodiagnosis of visceral leishmaniasis. Ann. Trop. Med. Parasitol. 72:213-218.
24. Jaffe, C. L., and M. Zalis. 1988. Purification of two Leishmania donovani membrane proteins recognized by sera from patients with visceral leishmaniasis. Mol. Biochem. Parasitol. 27:53-62.
25. Jensen, A. T., K. Kemp, T. G. Theander, and E. Handman. 2001. Cloning, expression and antigenicity of the L. donovani reductase. APMIS 109:461-468.
26. Kar, K. 1995. Serodiagnosis of leishmaniasis. Crit. Rev. Microbiol. 21:123-152.
27. Kaur, K. J., and L. Ruben. 1994. Protein translation elongation factor 1 α from Tiypanosoma brucei binds calmodulin. J. Biol. Chem. 269:23045-23050.
28. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
29. Liu, G., B. T. Edmonds, and J. Condeelis. 1996. pH, EF-1alpha and the cytoskeleton. Trends Cell. Biol. 6:168-171.
30. Louzir, H., F. Tebourski, D. F. Smith, R. B. Ismail, and K. Dellagi. 1994. Antibodies to Leishmania donovani infantum heat-shock protein 70 in human visceral leishmaniasis. J. Infect. Dis. 169:1183-1184.
31. Maalej, I. A., M. Chenick, H. Louzir, A. Ben Salah, C. Bahloul, F. Amri, and K. Dellagi. 2003. Comparative evaluation of ELISAs based on ten recombinant or purified Leishmania antigens for the serodiagnosis of Mediterranean visceral leishmaniasis. Am. J. Trop. Med. Hyg. 68:312-320.
32. Margutti, P., E. Ortona, S. Vaccari, S. Barca, R. Rigano, A. Teggi, F. Muhschlegel, M. Frosch, and A. Siracusano. 1999. Cloning and expression of a cDNA encoding an elongation factor 1beta/delta protein from Echinococcus granulosus with immunogenic activity. Parasite Immunol. 21:485-492.
33. Martin, S. K., L. Thuita-Harun, M. Adoyo-Adoyo, and K. M. Wasunna. 1998. A diagnostic ELISA for visceral leishmaniasis, based on antigen from media conditioned by Leishmania donovani promastigotes. Ann. Trop. Med. Parasitol. 62:571-577.
34. Matsudaira, P. 1987. Sequence from picomole quantities of proteins electroblotted onto polyvinylidene difluoride membranes. J. Biol. Chem. 262: 10035-10038.
35. Merrifield, R. B. 1963. Solid phase peptide synthesis. I. The synthesis of a tetrapeptide. J. Am. Chem. Soc. 85:2149-2154.
36. Mougneau, E., F. Altare, A. E. Wakil, S. Zheng, T. Coppola, Z. E. Wang, R. Waldmann, R. M. Locksley, and N. Glaichenhaus. 1995. Expression cloning of a protective Leishmania antigen. Science 268:563-566.
37. Murray, P. J., and T. W. Spithill. 1991. Variants of a Leishmania surface antigen derived from a multigenic family. J. Biol. Chem. 266:24477-24484.
38. Nandan, D., T. Yi, M. Lopez, C. Lai, and N. E. Reiner. 2002. Leishmania EF-1alpha activates the Src homology 2 domain containing tyrosine phosphatase SHP-1 leading to macrophage deactivation. J. Biol. Chem. 277: 50190-50197.
39. O'Farrell, P. Z., H. M. Goodman, and P. H. O'Farrell. 1977. High resolution two-dimensional electrophoresis of basic as well as acid proteins. Cell 12: 1133-1142,
40. Okong'o-Odera, E. A., A. Jorgen, L. Kurtzhals, A. S. Hey, and A. Kharazmi. 1993. Measurement of serum antibodies against native Leishmania gp63 distinguishes between ongoing and previous L. donovani infection. APMIS 101:642-646.
41. Okong'o-Odera, E. A., A. Wamachi, J. M. Kagai, J. A. Kurtzhals, J. I. Githure, A. S. Hey, J. B. Were, D., K. Koech, E. S. Mitena, and A. Kharazmi. 1993. Field application of an ELISA using redefined Leishmania antigen for the detection of visceral leishmaniasis. Trans. R. Soc. Trop. Med. Hyg. 87:423-424.
42. Ortona, E., P. Margutti, S. Vaccari, R. Rigano, E. Profumo, B. Buttari, A. Chersi, A. Teggi, and A. Siracusano. 2001. Elongation factor 1 beta/delta of Echinococcus granulosus and allergic manifestations in human cystic echi-nococcosis. Clin. Exp. Immunol. 125:110-116.
43. Ouelhazi, L., M. Filali, A. Décendit, J. C. Chenieux, and M. Rideau. 1993. Differential protein accumulation in zeatin-and 2,4-D-treated cells of Catharantus roseus. Correlation with indole alkaloid biosynthesis. Plant Physiol. Biochem. 31:421-431.
44. Pearson, R. D., and A. deq Ueiroz Souza. 1996. Clinical spectrum of leishmaniasis. Clin. Infect. Dis. 22:1-13.
45. Pfaff, E., M. Mussgay, H. O. Böhm, G. E. Schulz, and H. Schaller. 1982. Antibodies against a preselected peptide recognize and neutralize foot and mouth disease virus. EMBO J. 1:869-874.
46. Priest, J. W., and S. L. Hajduk. 1996. In vitro import of the Rieske iron-sulphur proteins by trypanosome mitochondria. J. Biol. Chem. 271:20060-20069.
47. Probst, P., E. Stromberg, H. W. Ghalib, M. Mozel, R. Badaro, S. G. Reed, and J. R. Webb. 2001. Identification and characterization of T cell-stimulating antigens from Leishmania by CD4 T cell expression cloning. J. Immunol. 166:498-505.
48. Quijada, L., J. M. Requena, M. Soto, and C. Alonso. 1998. Analysis of the antigenic properties of the L. infantum Hsp70: design of synthetic peptides for specific serodiagnosis of human leishmaniasis. Immunol. Lett. 63:169-174.
49. Rabilloud, T., J. M. Strub, S. Luche, A. Van Dorsselaer, and J. Lunardi. 2001. A comparison between Sypro Ruby and ruthenium II Tris (bathophenanthroline disulfonate) as fluorescent strains for protein detection in gels. Proteomics 5:699-704.
50. Ramagli, L. S., and L. U. Rodriguez. 1985. Quantification of microgram amounts of proteins in two-dimensional polyacrylamide gel electrophoresis sample buffer. Electrophoresis 6:559-563.
51. Reed, S. G., R. Badaro, and R. M. Lloyd. 1987. Identification of specific and cross-reactive antigens of Leishmania donovani chagasi by human infection sera. J. Immunol. 138:1596-1601.
52. Requena, J. M., C. Alonso, and M. Soto. 2000. Evolutionary conserved proteins as prominent immunogens during Leishmania infections. Parasitol. Today 16:246-250.
53. Rolland, L., V. Zilberfarb, A. Furtado, and M. Gentilini. 1994. Identification of a 94-kilodalton antigen on Leishmania promastigote forms and its specific recognition in human and canine visceral leishmaniasis. Parasite Immunol. 16:599-608.
54. Rolland-Burger, L., X. Rolland, C. W. Grieve, and L. Monjour. 1991. Immunoblot analysis of the humoral immune response to Leishmania donovani infantum polypeptides in human visceral leishmaniasis. J. Clin. Microbiol. 29:1429-1435.
55. Samaras, N., and T. W. Spithill. 1989. The developmentally regulated P100/HE gene of Leishmania major shows homology to a superfamily of reductase genes. J. Biol. Chem. 264:4251-4254.
56. Shreffler, W. J., J. M. Burns, Jr., R. Badaro, H. W. Ghalib, L. L. Button, W. R. McMaster, and S. G. Reed. 1993. Antibody responses of visceral leishmaniasis patients to gp63. a major surface glycoprotein of Leishmania species. J. Infect. Dis. 167:426-430.
57. Soto, M., J. M., Requena, L. C. Gomez, I. Navarete, and C. Alonso. 1992. Molecular characterization of a Leishmania donovani infantum antigen identified as histone H2A. Eur. J. Biochem. 205:211-216.
58. Soto, M., J. M. Requena, L. Quijada, M. Garcia, F. Guzman, M. E. Patarroyo, and C. Alonso. 1995. Mapping of the linear antigenic determinants from the Leishmania infantum histone H2A recognized by sera from dogs with leishmaniasis. Immunol. Lett. 48:209-214.
59. Soto, M., J. M. Requena, L. Quijada, M. J. Perez, C. G. Nieto, F. Guzman, M. E. Patarroyo, and C. Alonso. 1999. Antigenicity of the Leishmania infantum histones H2B and H4 during canine viscerocutaneous leishmaniasis. Clin. Exp. Immunol. 115:342-349.
60. Stuart, M. K. 1998. An antibody diagnostic for hymenopteran parasitism is specific for a homologue of elongation factor-1 alpha. Arch. Insect Biochem. Physiol. 39:1-8.
61. Tebourski, F., A. El Gaied, H. Louzir, R. Ben Ismail, R. Kammoun, and K. Dellagi. 1994. Identification of an immunodominant 32-kilodalton membrane protein of Leishmania donovani infantum promastigotes suitable for specific diagnosis of Mediterranean visceral leishmaniasis. J. Clin. Microbiol. 32:2474-2480.
62. Voller, A., D. E. Bidwell, and A. Bartlett. 1976. Enzyme immunoassays in diagnostic medicine. Theory and practice. Bull. W. H. O. 53:55-65.
63. Yang, F. M. Demma, M. Warren, S. Dharmawardhane, and J. Condeelis. 1990. Identification of an actin-binding protein from Dictyostelium as elongation factor 1a. Nature 347:494-496.